Tipiracil Hydrochloride; Trifluridine Patent Expiration

Tipiracil Hydrochloride; Trifluridine is Used for treating metastatic colorectal cancer in patients previously treated with specific chemotherapy combinations. It was first introduced by Taiho Oncology Inc in its drug Lonsurf on Sep 22, 2015. 2 different companies have introduced drugs containing Tipiracil Hydrochloride; Trifluridine.


Tipiracil Hydrochloride; Trifluridine Patents

Given below is the list of patents protecting Tipiracil Hydrochloride; Trifluridine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lonsurf US10456399 Method for treating cancer patients with severe renal impairment Feb 03, 2037 Taiho Oncology
Lonsurf US10960004 Method for treating cancer patients with severe renal impairment Feb 03, 2037 Taiho Oncology
Lonsurf US9943537 Antitumor agent and antitumor effect enhancer Sep 05, 2034 Taiho Oncology
Lonsurf US10457666 Stable crystal form of tipiracil hydrochloride and crystallization method for the same Jun 17, 2034 Taiho Oncology
Lonsurf US9527833 Stable crystal form of tipiracil hydrochloride and crystallization method for the same Jun 17, 2034 Taiho Oncology
Lonsurf USRE46284 Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor Sep 22, 2029 Taiho Oncology
Lonsurf US7799783 Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor Dec 16, 2026 Taiho Oncology
Lonsurf US6479500 Agents for alleviating side effects Mar 16, 2020

(Expired)

Taiho Oncology
Lonsurf US5744475 Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same Mar 28, 2016

(Expired)

Taiho Oncology



Tipiracil Hydrochloride; Trifluridine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Tipiracil Hydrochloride; Trifluridine Generic API Manufacturers

Several generic applications have been filed for Tipiracil Hydrochloride; Trifluridine.

Given below is the list of companies who have filed for Tipiracil Hydrochloride; Trifluridine generic, along with the locations of their manufacturing plants worldwide.


1. NATCO

Natco Pharma Ltd has filed for 2 different strengths of generic version for Tipiracil Hydrochloride; Trifluridine. All of these versions come by the name TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE. Given below are the details of the strengths of this generic introduced by Natco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 6.14MG BASE; 15MG

tablet Prescription ORAL AB Jun 13, 2023
EQ 8.19MG BASE; 20MG

tablet Prescription ORAL AB Jun 13, 2023


Manufacturing Plant Locations
New

Natco's manufacturing plants are situated in 2 countries - United Kingdom, India. Given below are the details of these plant locations as well as the firm names of Natco as present at those locations.

Country City Firm Name
United Kingdom
Buckingham Natco Foods Ltd
Hayes Natco Cash and Carry
India
Paravada Natco Pharma Limited
Hyderabad Natco Pharma Limited
Rangareddy NATCO Pharma Limited
Rangareddy District Natco Pharma Ltd. - Chemical Division
Hyderabad NATCO PHARMA LTD
Chennai NATCO Pharma Limited Chemical Division Chennai